Anti-CD20 monoclonal antibody:
Treatment of chronic lymphocytic leukaemia (CLL)
Treatment of follicular lymphoma (FL)
Drug interactions
Potentially hazardous interactions with other drugs
Cytotoxics: chlorambucil or bendamustine may
increase neutropenia.
Live vaccines: avoid concomitant use.
Metabolism
Not hepatically metabolised.
The elimination of obinutuzumab is comprised of a
linear clearance pathway and a time dependent non-linear
clearance pathway.
